Scientific ReportsCancer BiologyPeer-reviewed journal article
New Dual Inducible Cellular Model to Investigate Temporal Control of Oncogenic Cooperating Genes
Abstract
The study of cooperating genes in cancer can lead to mechanistic understanding and identifying potential therapeutic targets. To facilitate these types of studies, we developed a new dual-inducible system utilizing the tetracycline- and cumate-inducible systems driving HES3 and the PAX3::FOXO1 fusion-oncogene, respectively, as cooperating genes from fusion-positive rhabdomyosarcoma. With this new model, we can independently induce expression of either HES3 or PAX3::FOXO1, as well as simultaneously induce expression of both genes. This new model will allow us to further investigate the cooperation between HES3 and PAX3::FOXO1 including the temporal requirements for genetic cooperation. This dual-inducible model can be adapted for any cooperating genes, allowing for independent, simultaneous, or temporally controlled gene expression.
- Citations
- 4
- FWCI
- 0.68
- Field percentile
- top 32%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Fusion transcription factor dosage controls cell state in rhabdomyosarcoma
Rachel A. Hoffman, Meng Wang, … Benjamin Z. Stanton·bioRxiv·May 16, 2025
- HES3-dependent regulatory functions in development and fusion-positive rhabdomyosarcoma
Jack P. Kucinski, Matthew R. Kent, … Genevieve C. Kendall·bioRxiv·May 8, 2026
- Co-regulation and functional cooperativity of FOXM1 and RHNO1 bidirectional genes in ovarian cancer
C. J. Barger, C. Branick, … A. Karpf·bioRxiv·Jun 4, 2019
- RUNX2 inhibition disrupts a PAX3::FOXO1-RUNX2 feed-forward loop and dismantles oncogenic gene programs in fusion-positive rhabdomyosarcoma
Elizabeth A. Mendes, Aanandi Munshi, … Corinne Mary Linardic·bioRxiv·Jul 21, 2025
- A common druggable signature of oncogenic CMYC, mutant KRAS and mutant p53 reveals functional redundancy and competition of the oncogenes in cancer
M. Grzes, A. Jaiswar, … D. Walerych·bioRxiv·Dec 20, 2023
- Myogenic and neural transcriptional circuitry determines PAX3::FOXO1 driven initiation of rhabdomyosarcoma
Bradley T. Stevens, Yang Zhang, … Mark E. Hatley·bioRxiv·Oct 29, 2026